

| Numéro de catalogue | AB941518 |
|---|---|
| Description |
Anti-Ranibizumab Neutralizing Antibody ELISA kit (AB941518) — Quantitative sandwich ELISA for Anti-Ranibizumab Neutralizing Antibody. Sample: Plasma, Serum. Range: 15.625-1, 000 ng/ml.
Highlights
|
| Type d'échantillon | Plasma, Serum |
| Plage | 15.625-1, 000 ng/ml |
| Numéro d'accès | P15692 |
| Applications | ELISA |
| Méthode de détection | Colorimetric |
| Type de test | Quantitative |
| Retraitement | 80-120% |
| Expédition | 2-8 ℃ |
| Stabilité et stockage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Spécifications | Ranibizumab |
| Noms alternatifs | Fab-12 variant Y0317, RhuFab, 347396-82-1 |
| Contexte | Vascular endothelial growth factor A, long form (Ranibizumab) is a ~43 kDa protein. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A. Involved in protecting cells from hypoxia-mediated cell death. 1. Katsman, M. et al. (2022) Cells 11. PMID: 35455969 |
| Note | For Research Use Only. |




Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.
Courrier : [email protected]
+86-027-65523339
Bâtiment C, No. 666, Rue Shendunsi, Wuhan, 430206, Chine
中文
English
한국어
日本語
Español
Français
Русский